How Dexcom and Abbott are moving beyond diabetes


Share post:

According to the Centers for Disease Control and Prevention, more than 37 million people in the U.S. have diabetes. That’s a little more than 11% of the entire population. 

A diabetic’s body doesn’t make enough or any insulin at all. Those with the disease must regularly monitor their blood sugar. This has been traditionally done with glucometers, which diabetics use to prick their fingers over and over again for drops of blood. But over the last decade, technology like continuous glucose monitoring has been on the rise. 

Abbott and Dexcom are the two most dominant players in the space. Both companies have seen increased growth. 

The technology is also being marketed by several health and wellness apps as many companies see benefits for those who don’t have diabetes.

CNBC spoke with both Abbott and Dexcom about the technology inside continuous glucose monitors and how they see it expanding.

Watch the video to learn more.

Source link


Related articles

Apply at least 6 months ahead

Fatcamera | E+ | Getty ImagesPassport applications are at an all-time highMore Americans planned trips abroad this...

Apple CEO Tim Cook appears in New York to celebrate iPhone 15 release

Apple CEO Tim Cook opened the company's Fifth Avenue store Friday in New York to celebrate the...

Why it’s cheaper to buy holiday flights in October

'Prices will start to rise after about Oct.14th'Travelers are seeing cheaper flights this year. Domestic round-trip fares...

Ethereum founder on U.S. crypto crackdown

Ethereum co-founder Vitalik Buterin in Prague, where he finds refuge with like-minded programmers looking to change the...